Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals (Q83376683)
Jump to navigation
Jump to search
scientific article published on 19 March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals |
scientific article published on 19 March 2010 |
Statements
Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals (English)
Wolfgang Steudel
Colleen Dingmann
Yan-Ling Zhang
Jamie Bendrick-Peart
Claudia Clavijo
John Shulze
Ronald Betts